ARCHIVES

Preclinical Models: NCI Advisors OK Plan For Mouse Models Consortium

This article is from The Cancer Letter archive.

Vol. 24 No. 10 | March 13, 1998

Download PDF Visit The Full Archive

Related Articles

More Cost-Effective To Use Cetuximab In Patients With Wild-Type KRAS Gene

August 28, 2009

DCT Board Approves Proposals For Increased Efforts With Biological Response Modifiers, Oks Contracts

November 9, 1979

Gallo’s Deputy Removed Pending Investigation

January 11, 1991

Alexion In Collaboration With Netherlands Center.

November 30, 2001

In Brief: Cancer Panel To Meet In Seattle, Houston, Chicago; Wisconsin’s Robert Johnson Dies; Goldin Retires

August 27, 1982

Study: Nine Years After Diagnosis 9.3% of Survivors Still Smoke

August 29, 2014